Clinical Trial Update: Assessment of the Predictive Value of Anti-beta1AR and Anti-L-CaC Antibodies in the Evolution to Dilated Cardiomyopathy in Patients With Acute Viral Myocarditis

View source ↗

Summary

A clinical trial update examining whether anti-beta1 adrenergic receptor antibodies and anti-L-CaC antibodies can predict progression from acute viral myocardit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dilated Cardiomyopathy
• Viral Myocarditis

Drugs mentioned

• Anti-beta1 adrenergic receptor antibodies (anti-beta1AR antibodies)
• anti-L-CaC antibodies (L-type calcium channel antibodies)

Snippet

Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | Conditions: Viral Myocarditis | Status: RECRUITING